Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/31/15
End: 08/31/16
Due: 08/31/17
Phase: N/A
Priority: Normal
Start: 08/28/17
End: 01/25/20
Due: 01/25/21
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety Study of CN-105 Neuroprotective Peptide for Intracerebral Hemorrhage | NCT02670824 | AegisCN LLC | user2@example.com | None | 2015-12-31 | 2016-08-31 | 2017-08-31 | - | - | 2025-07-14 |
| A Proof of Concept Study to Evaluate CN-105 in ICH Patients | NCT03168581 | AegisCN LLC | user2@example.com | None | 2017-08-28 | 2020-01-25 | 2021-01-25 | - | - | 2025-07-14 |